1. P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MYELOMA MAY HAVE A LOWER RISK OF PROGRESSION COMPARED TO WHITE PATIENTS. (23rd June 2022) Authors: Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U.; Tan, C.; Derkach, A.; Lahoud, O.; Landau, H. J.; Shah, G. L.; Scordo, M.; Chung, D. J.; Giralt, S. A.; Usmani, S. Z.; Landgren, O.; Hultcrantz, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S177: EVALUATING SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER FOR MULTIPLE MYELOMA. (23rd June 2022) Authors: Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U.; Tan, C.; Derkach, A.; Lahoud, O.; Landau, H. J.; Shah, G. L.; Scordo, M.; Chung, D. J.; Giralt, S. A.; Usmani, S. Z.; Landgren, O.; Hultcrantz, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗